Mouse Anti-LAMA5 Antibody (P3H9) (CBMAB-0100-YC)

Luo, S., Liu, Z. G., Wang, J., Luo, J. X., Ye, X. G., Li, X., ... & Liao, W. P. (2022). Recessive LAMA5 variants associated with partial epilepsy and spasms in infancy. Frontiers in Molecular Neuroscience, 15, 825390.

Falcone, S., Nicol, T., Blease, A., Randles, M. J., Angus, E., Page, A., ... & Potter, P. K. (2022). A novel model of nephrotic syndrome results from a point mutation in Lama5 and is modified by genetic background. Kidney International, 101(3), 527-540.

Savige, J., & Harraka, P. (2021). Pathogenic LAMA5 variants and kidney disease. Kidney360, 2(12), 1876.

Taniguchi, Y., Sekiguchi, K., Tashiro, A., Sugawara, N., Sakaguchi, H., Umeda, C., ... & Nozu, K. (2021). Clear evidence of LAMA5 gene biallelic truncating variants causing infantile nephrotic syndrome. Kidney360, 2(12), 1968.

Zhang, X., Li, Q., Jiang, W., Xiong, X., Li, H., Zhao, J., & Qi, H. (2020). LAMA5 promotes human umbilical vein endothelial cells migration, proliferation, and angiogenesis and is decreased in preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine, 33(7), 1114-1124.

Napolitano, F., Di Iorio, V., Di Iorio, G., Melone, M. A. B., Gianfrancesco, F., Simonelli, F., ... & Sampaolo, S. (2019). Early posterior vitreous detachment is associated with LAMA5 dominant mutation. Ophthalmic Genetics, 40(1), 39-42.

Braun, D. A., Warejko, J. K., Ashraf, S., Tan, W., Daga, A., Schneider, R., ... & Hildebrandt, F. (2019). Genetic variants in the LAMA5 gene in pediatric nephrotic syndrome. Nephrology Dialysis Transplantation, 34(3), 485-493.

Gordon-Weeks, A., Lim, S. Y., Yuzhalin, A., Lucotti, S., Vermeer, J. A. F., Jones, K., ... & Muschel, R. J. (2019). Tumour-derived laminin α5 (LAMA5) promotes colorectal liver metastasis growth, branching angiogenesis and notch pathway inhibition. Cancers, 11(5), 630.

Voskarides, K., Papagregoriou, G., Hadjipanagi, D., Petrou, I., Savva, I., Elia, A., ... & Deltas, C. (2018). COL4A5 and LAMA5 variants co-inherited in familial hematuria: digenic inheritance or genetic modifier effect?. BMC nephrology, 19, 1-8.

Maselli, R. A., Arredondo, J., Vázquez, J., Chong, J. X., Bamshad, M. J., Nickerson, D. A., ... & McDonald, C. M. (2018). A presynaptic congenital myasthenic syndrome attributed to a homozygous sequence variant in LAMA5. Annals of the New York Academy of Sciences, 1413(1), 119-125.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols